Tamoxifen is a drug that interferes with the activity of estrogen. It has been used for more than 30 years to treat and to prevent breast cancer.
In addition, since January 2000, Tamoxifen has been included in the list of prohibited substances by the International Olympic Committee. So, the presence of these compounds in urine is a doping proof. The analysis of complex samples, like biofluids, requires a sample preparation step prior to analysis.
AFFINIMIP® SPE Tamoxifen are selective solid phase extraction cartridges that selectively clean and concentrate Tamoxifen and its metabolites prior to analysis by HPLC.